Emisjoner, børsnoteringer m.m.

Recipharm AB (publ) – Rights Issue

Recipharn

(04.06.2020) DNB Markets is acting as Financial Adviser and Joint Lead Manager in relation to the preferential rights issue (the “Rights Issue”) in Recipharm AB (publ) (“Recipharm” or the “Company”) on Nasdaq Stockholm.